BeStock  
Stocks › Biotechnology › AVBP

ArriVent BioPharma AVBP

US equityMarket cap rank #3544Biotechnology
$10.52 −$0.74 (-6.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.52 0.00%
Open$11.00
Prev close$11.26
Day range$10.38 – $11.35
Volume1.05M
Market cap$544.13M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership102.1%-3.64 pts vs. prior quarter
Institutions holding193-3 vs. prior quarter
Insider trades (recent)30 buys / 1 sellsNet buying
Short interest11.76% of floatDays to cover 3.4 · as of 30 Oct 2026
Short-sale volume share23.6%5-day average of daily volume

Short-sale volume as % of daily volume

13%20%27%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.58M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$6.4MSuper−$1.2MBig−$176.2KMid−$5.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 37.2% of shares outstanding.

Largest holders

  • Montanova Capital, LLC8.73%
  • Infinitum Asset Management, LLC8.58%
  • Hillhouse Capital Management, Ltd.7.60%
  • BlackRock6.59%
  • FMR5.74%
  • OrbiMed Advisors LLC5.56%
  • Vivo Capital, LLC5.08%
  • HBM Healthcare Investments AG4.24%

By investor type

  • VC/PE Fund37.40%
  • Hedge Fund30.41%
  • Mutual Fund30.13%
  • Public Company2.41%
  • Individual/Insider1.81%
  • Private Company1.35%
  • Government Pension Fund0.17%
  • Insurance Company0.15%

Reported short interest has fallen from 16.69% to 11.76% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Vivo Capital, LLC VC/PE Fund 2026/Q3 +943,575 5.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +236,380 3.9%
FMR Mutual Fund 2026/Q3 +188,090 5.7%
E Fund Management Co., Ltd. Mutual Fund 2026/Q3 +168,476 0.5%
BlackRock Mutual Fund 2026/Q3 +156,923 6.6%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +113,489 0.6%
UBS Asset Management Mutual Fund 2026/Q3 +102,927 1.1%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +82,592 2.0%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +75,135 0.1%
Vivo Capital, LLC VC/PE Fund 2026/Q3 +796,181 3.4%
BlackRock Mutual Fund 2026/Q3 +720,095 6.6%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +650,000 1.9%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +503,216 1.7%
Foresite Capital Management, LLC VC/PE Fund 2026/Q3 +301,341 0.6%
Infinitum Asset Management, LLC Hedge Fund 2026/Q3 +289,461 8.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Oct 2026 Robin LaChapelle Co-Founder & COO Derivative Exercise and Retained +40,693 $6.24 570,906
17 Jun 2026 Kristine Peterson Lead Independent Director Other Derivative Acquisition +13,562 $31.74 13,562
17 Jun 2026 Merdad Parsey Independent Director Other Derivative Acquisition +13,562 $31.74 13,562
17 Jun 2026 John Hohneker Independent Director Other Derivative Acquisition +13,562 $31.74 13,562
17 Jun 2026 Christian Nolet Independent Director Other Derivative Acquisition +13,562 $31.74 13,562
1 Feb 2026 Zhengbin Yao Chairperson & CEO Other Derivative Acquisition +550,000 $22.67 550,000
1 Feb 2026 Robin LaChapelle Co-Founder & COO Other Derivative Acquisition +130,000 $22.67 130,000
1 Feb 2026 Stuart Lutzker Co-Founder, President of Research & Development and Director Other Derivative Acquisition +150,000 $22.67 150,000
1 Feb 2026 Winston Kung Chief Financial Officer Other Derivative Acquisition +140,000 $22.67 140,000
1 Feb 2026 James Kastenmayer General Counsel Other Derivative Acquisition +130,000 $22.67 130,000
9 Dec 2025 Hillhouse Capital Management, Ltd. Open Market Disposition -555,555 $23.37 3,741,271
10 Jul 2025 Robin LaChapelle Co-Founder & COO Derivative Exercise and Retained +11,153 $2.28 530,213
17 Jun 2025 Kristine Peterson Lead Independent Director Other Derivative Acquisition +15,502 $24.89 15,502
17 Jun 2025 Merdad Parsey Independent Director Other Derivative Acquisition +15,502 $24.89 15,502
17 Jun 2025 John Hohneker Independent Director Other Derivative Acquisition +15,502 $24.89 15,502
17 Jun 2025 Christian Nolet Independent Director Other Derivative Acquisition +15,502 $24.89 15,502
27 Apr 2025 Merdad Parsey Independent Director Other Derivative Acquisition +28,346 $20.92 28,346
2 Feb 2025 Zhengbin Yao Chairperson & CEO Other Derivative Acquisition +380,000 $27.56 380,000
2 Feb 2025 Robin LaChapelle Co-Founder & COO Other Derivative Acquisition +120,000 $27.56 120,000
2 Feb 2025 Stuart Lutzker Co-Founder, President of Research & Development and Director Other Derivative Acquisition +120,000 $27.56 120,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,797,018 11.8% 3.4
15 Oct 2026 6,806,605 13.8% 2.2
30 Sep 2026 8,451,472 17.1% 11.3
15 Sep 2026 8,766,246 17.8% 17.7
31 Aug 2026 8,691,715 17.6% 20.4
14 Aug 2026 8,227,393 16.7% 21.8

Discussion

No comments yet — be the first to weigh in on AVBP.

Sign in to join the discussion.

Scroll to Top